Canada Pension Plan Investment Board’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-189,100
Closed -$320K 1842
2026
Q1
$320K Buy
189,100
+45,000
+31% +$92.6K ﹤0.01% 1399
2025
Q4
$285K Buy
+144,100
New +$461K ﹤0.01% 1536
2025
Q1
Sell
-4,500
Closed -$10.6K 1459
2024
Q4
$10.6K Buy
+4,500
New +$79K ﹤0.01% 1372
2014
Q2
Sell
-400
Closed -$15K 1288
2014
Q1
$15K Buy
+400
New +$14.1K ﹤0.01% 1256

Other funds holding FLNA

Canada Pension Plan Investment Board's FLNA Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 189,100 shares — an estimated $320K sold.

Canada Pension Plan Investment Board first reported a position in FLNA in Q1 2014 and held it in 4 quarters. The position peaked at $320K in Q1 2026. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 189,100 Filana Therapeutics shares in Q2 2026, an estimated $320K.
  • Canada Pension Plan Investment Board first reported a position in Filana Therapeutics in Q1 2014 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Filana Therapeutics position peaked at $320K in Q1 2026.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.